Literature DB >> 21566225

Genome-wide characterization of miR-34a induced changes in protein and mRNA expression by a combined pulsed SILAC and microarray analysis.

Markus Kaller1, Sven-Thorsten Liffers, Silke Oeljeklaus, Katja Kuhlmann, Simone Röh, Reinhard Hoffmann, Bettina Warscheid, Heiko Hermeking.   

Abstract

The gene encoding the miR-34a microRNA is a transcriptional target of the p53 tumor suppressor protein and subject to epigenetic inactivation in colorectal cancer and numerous other tumor types. Here, we combined pulsed SILAC (pSILAC) and microarray analyses to identify miR-34a-induced changes in protein and mRNA expression. pSILAC allowed to quantify the de novo protein synthesis of 1206 proteins after activation of a conditional miR-34a allele in a colorectal cancer cell line. ∼19% of the detected proteins were differentially regulated, with 113 proteins being down- and 115 up-regulated. The proteins with a miR-34a seed-matching-sequence in the 3'-untranslated region (UTR) of the corresponding mRNA showed a clear bias toward translational repression. Proteins involved in DNA replication, e.g. the MCM proteins, and cell proliferation, were over-represented among indirectly down-regulated proteins lacking a miR-34a seed-match. The decrease in de novo protein synthesis of direct miR-34a targets correlated with reduced levels of the corresponding mRNA in most cases, indicating an interdependence of both types of regulation. In addition, 43 mRNAs encoding proteins not detected by pSILAC were down-regulated after miR-34a expression and contained miR-34a seed-matches. The direct regulation of selected miR-34a target-mRNAs was confirmed using reporter assays. Via down-regulation of the proteins encoded by these mRNAs miR-34a presumably inhibits glycolysis (LDHA), WNT-signaling (LEF1), invasion/migration (AXL) and lipid metabolism (ACSL1, ACSL4). Furthermore, miR-34a may activate p53 by inhibiting its acetylation (MTA2, HDAC1) and degradation (YY1). In summary, miR-34a presumably participates in multiple tumor suppressive pathways by directly and indirectly suppressing the expression of numerous, critical proteins.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21566225      PMCID: PMC3149097          DOI: 10.1074/mcp.M111.010462

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  68 in total

1.  Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a.

Authors:  Qing-Rong Chen; Li-Rong Yu; Patricia Tsang; Jun S Wei; Young K Song; Adam Cheuk; Joon-Yong Chung; Stephen M Hewitt; Timothy D Veenstra; Javed Khan
Journal:  J Proteome Res       Date:  2010-12-23       Impact factor: 4.466

2.  A gene regulation system with four distinct expression levels.

Authors:  Christel Krueger; Christina Danke; Klaus Pfleiderer; Wolfgang Schuh; Hans-Martin Jäck; Susanne Lochner; Peter Gmeiner; Wolfgang Hillen; Christian Berens
Journal:  J Gene Med       Date:  2006-08       Impact factor: 4.565

Review 3.  Gene silencing by microRNAs: contributions of translational repression and mRNA decay.

Authors:  Eric Huntzinger; Elisa Izaurralde
Journal:  Nat Rev Genet       Date:  2011-02       Impact factor: 53.242

4.  Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas.

Authors:  Markus Vogt; Johanna Munding; Martha Grüner; Sven-Thorsten Liffers; Berlinda Verdoodt; Jennifer Hauk; Lars Steinstraesser; Andrea Tannapfel; Heiko Hermeking
Journal:  Virchows Arch       Date:  2011-01-12       Impact factor: 4.064

5.  Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer.

Authors:  G Mudduluru; P Ceppi; R Kumarswamy; G V Scagliotti; M Papotti; H Allgayer
Journal:  Oncogene       Date:  2011-02-14       Impact factor: 9.867

6.  Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice.

Authors:  Phong Trang; Jason F Wiggins; Christopher L Daige; Chris Cho; Michael Omotola; David Brown; Joanne B Weidhaas; Andreas G Bader; Frank J Slack
Journal:  Mol Ther       Date:  2011-03-22       Impact factor: 11.454

Review 7.  A parsimonious model for gene regulation by miRNAs.

Authors:  Sergej Djuranovic; Ali Nahvi; Rachel Green
Journal:  Science       Date:  2011-02-04       Impact factor: 47.728

8.  Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.

Authors:  Nina Raver-Shapira; Efi Marciano; Eti Meiri; Yael Spector; Nitzan Rosenfeld; Neta Moskovits; Zvi Bentwich; Moshe Oren
Journal:  Mol Cell       Date:  2007-05-31       Impact factor: 17.970

9.  The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.

Authors:  Can Liu; Kevin Kelnar; Bigang Liu; Xin Chen; Tammy Calhoun-Davis; Hangwen Li; Lubna Patrawala; Hong Yan; Collene Jeter; Sofia Honorio; Jason F Wiggins; Andreas G Bader; Randy Fagin; David Brown; Dean G Tang
Journal:  Nat Med       Date:  2011-01-16       Impact factor: 53.440

10.  Inducible microRNA expression by an all-in-one episomal vector system.

Authors:  Alexey Epanchintsev; Peter Jung; Antje Menssen; Heiko Hermeking
Journal:  Nucleic Acids Res       Date:  2006-09-22       Impact factor: 16.971

View more
  103 in total

Review 1.  MicroRNAs in liver disease.

Authors:  Xin Wei Wang; Niels H H Heegaard; Henrik Orum
Journal:  Gastroenterology       Date:  2012-04-11       Impact factor: 22.682

Review 2.  Regulation of senescence by microRNA biogenesis factors.

Authors:  Kotb Abdelmohsen; Subramanya Srikantan; Min-Ju Kang; Myriam Gorospe
Journal:  Ageing Res Rev       Date:  2012-01-28       Impact factor: 10.895

Review 3.  The emerging functions of the p53-miRNA network in stem cell biology.

Authors:  Chao-Po Lin; Yong Jin Choi; Geoffrey G Hicks; Lin He
Journal:  Cell Cycle       Date:  2012-06-01       Impact factor: 4.534

Review 4.  MicroRNA regulation and analytical methods in cancer cell metabolism.

Authors:  Ling-Fei Zhang; Shuai Jiang; Mo-Fang Liu
Journal:  Cell Mol Life Sci       Date:  2017-03-20       Impact factor: 9.261

5.  Identification of targets of tumor suppressor microRNA-34a using a reporter library system.

Authors:  Yoshiaki Ito; Atsushi Inoue; Timothy Seers; Yukari Hato; Arisa Igarashi; Tatsuya Toyama; Konstantin D Taganov; Mark P Boldin; Hiroshi Asahara
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-29       Impact factor: 11.205

Review 6.  The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer.

Authors:  Douglas K Graham; Deborah DeRyckere; Kurtis D Davies; H Shelton Earp
Journal:  Nat Rev Cancer       Date:  2014-12       Impact factor: 60.716

7.  Digital analysis and epigenetic regulation of the signature of rejection in colorectal cancer.

Authors:  Viktor H Koelzer; Lena Sokol; Stefan Zahnd; Lucine Christe; Heather Dawson; Martin D Berger; Daniel Inderbitzin; Inti Zlobec; Alessandro Lugli
Journal:  Oncoimmunology       Date:  2017-02-06       Impact factor: 8.110

8.  A combined approach of quantitative interaction proteomics and live-cell imaging reveals a regulatory role for endoplasmic reticulum (ER) reticulon homology proteins in peroxisome biogenesis.

Authors:  Christine David; Johannes Koch; Silke Oeljeklaus; Alexandra Laernsack; Sophie Melchior; Sebastian Wiese; Andreas Schummer; Ralf Erdmann; Bettina Warscheid; Cécile Brocard
Journal:  Mol Cell Proteomics       Date:  2013-05-20       Impact factor: 5.911

9.  MiR-34a suppresses amphiregulin and tumor metastatic potential of head and neck squamous cell carcinoma (HNSCC).

Authors:  Jiali Zhang; Yu Wang; Xinming Chen; Yi Zhou; Fangyan Jiang; Jirong Chen; Li Wang; Wen-Feng Zhang
Journal:  Oncotarget       Date:  2015-04-10

Review 10.  Non-coding RNAs: the new central dogma of cancer biology.

Authors:  Phei Er Saw; Xiaoding Xu; Jianing Chen; Er-Wei Song
Journal:  Sci China Life Sci       Date:  2020-09-11       Impact factor: 6.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.